Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Talactoferrin alfa in Severe Sepsis
NCT01273779Phase 3Suspended
- Sponsor
- Agennix AG
- Start
- Jun 2011
- Primary completion
- Jan 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 10
01
Overview
A Phase 3 trial of lactoferrin in sepsis, sponsored by Agennix AG. Started Jun 2011; status: suspended.
02
Drugs
lactoferrin
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT01273779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01273779.